All lobbying filings

T1INTERNATIONAL USA

Lobbying for T1INTERNATIONAL USA

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maine · House · posted Jan 19, 2026

Official filing document

Bills named in this filing 2

S 1553
PREVAIL Act
S 1546
Patent Eligibility Restoration Act of 2025

Lobbying activity 1

Health Issues

Issues related to the following bills: oS.1040: Drug Competition Enhancement Act oS.1041: Affordable Prescriptions for Patients Act oS.1095: Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act oS.1096: Preserve Access to Affordable Generics and Biosimilars Act oH.R.3160/S.1553: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act oH.R.3152/S.1546: Patent Eligibility Restoration (PERA) Act oH.R.3269: ETHIC Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.